Since assuming the executive leadership of the Life Sciences Center in July 2008, Dr. Windham-Bannister has been responsible for the overall implementation of the life sciences initiative, including staffing the center, developing policies and procedures, creating a brand, and formulating the investment strategy. The center’s portfolio of investment is promoting economic development, catalyzing innovation, strengthening Massachusetts’ global leadership position in the life sciences, and accelerating the commercialization of promising treatments, therapies and cures. Under Windham-Bannister’s leadership, in just three years the center has invested $218 million, leveraged another $700 million in matching investment capital, and created over 7,000 new life sciences jobs in the commonwealth.
Before assuming her role at the Life Sciences Center, Dr. Windham-Bannister was a founding partner of Abt Bio-Pharma Solutions (ABS), a boutique consulting firm serving life sciences companies. Within ABS, Windham-Bannister managed the Commercial Strategy Group. In her 35 year consulting career, she has been instrumental in the successful launch of a number of well-known therapeutics, medical devices, and novel biomarkers.
Dr. Windham-Bannister has co-authored two books: Competitive Strategy for Health Care Organizations and Medicaid and Other Experiments in State Health Policy. She also has written numerous articles on competition in today’s health care marketplace. She holds a B.A. from Wellesley College, a doctorate in health policy and management from the Heller School at Brandeis University, and was a post-doctoral fellow at Harvard University’s John F. Kennedy School. She completed her doctoral work under a fellowship from the Ford Foundation.